RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

52 hedge funds and large institutions have $134M invested in Regulus Therapeutics in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 3 closing their positions.

Holders
52
Holders Change
+12
Holders Change %
+30%
% of All Funds
1.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
23
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$57.8M
2
HM
2
HealthCor Management
New York
$9.19M
3
BCPEM
3
Bain Capital Public Equity Management
Massachusetts
$8.49M
4
Jennison Associates
4
Jennison Associates
New York
$3.38M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$2.51M

Top Sellers

1
EA
1
Emerald Advisers
Pennsylvania
$3.54M
2
EMFAT
2
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.79M
3
Morgan Stanley
3
Morgan Stanley
New York
$0
4
SIM
4
Spark Investment Management
New York
$0
5
BI
5
BVF Inc
California
$2.2M
Name Market Value Shares Shares
Change 		Shares
Change %
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10 9 +1 +13%
Morgan Stanley
52
Morgan Stanley
New York
– – -334 Closed
SIM
53
Spark Investment Management
New York
– – -296 Closed
PAM
54
Panagora Asset Management
Massachusetts
– – -181 Closed
Citigroup
55
Citigroup
New York
– – – –
1 2
3